Hexobendine
CARDIOVASCULAR SYSTEM
Also known as: ditrimin, ditrimine, ditrymine, hexabendin, hexabendine, hexobendin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Hexobendine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including SCN1A|SCN2A|SCN3A.
- Molecular targets: SCN1A|SCN2A|SCN3A (1 listed in DrugCentral).
- ATC code: C01DX06 (Other vasodilators used in cardiac diseases).
- Molecular formula: C30H44N2O10; molecular weight 592.69 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sodium channel alpha subunits; brain (Types I, II, III) | SCN1A|SCN2A|SCN3A | unknown | IC50 5.85 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01DX06 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › VASODILATORS USED IN CARDIAC DISEASES › Other vasodilators used in cardiac diseases |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Hexobendine is on its molecule page.
| Molecular formula | C30H44N2O10 |
|---|---|
| Molecular weight | 592.69 g/mol |
| CAS number | 54-03-5 |
| InChIKey | KRQAMFQCSAJCRH-UHFFFAOYSA-N |
| PubChem CID | 5777 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Hexobendine work?
Its molecular targets in DrugCentral include SCN1A|SCN2A|SCN3A.
What is the chemical formula of Hexobendine?
Hexobendine has the molecular formula C30H44N2O10 and a molecular weight of 592.69 g/mol.
Browse: all drugs starting with H · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1370 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL127300 — compound record and bioactivity
- PubChem CID 5777 — chemical identifiers
- DrugBank DB13265 — drug record
- FDA UNII B6X4SYR93B — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.